Contents

	Advocate-General's Opinion In Roche Nederland BV V Primus And Goldenberg: End Of The Spider In The Web?
	The ABPI's Code Of Practice For The Pharmaceutical Industry 2006
	The WTO Hong Kong Conference - Patent Protection And Genetic Origin
	Combination Products May Be Entitled To The Benefit Of Supplementary Protection Certificates
	The Freedom Of Information Act - It's Impact On The Pharmaceutical Sector 12 Months On
	2005 Crackdown On Animal Rights Extremism And Tips For Protecting Your Business
	EC Commission And FTC Approve The Acquisition By Johnson & Johnson Of Guidant Corporation
	EC Commissions Approves Two Mergers Relating To Generic Medicines In 2005
	Biosciences Companies On Aim

Please click on the headline to view the full article.

TO VIEW A PRINTER FRIENDLY VERSION, FOLLOW THIS LINK »

DLA Piper's Pharmaceutical and Bioscience Group

The pharmaceutical and bioscience industries are highly regulated and can present many legal hurdles. DLA Piper has set out to construct a leading team of industry experts. The results (a combination of our international merger and targeted recruitment) has produced one of the finest pharmaceutical and biosciences teams in the world. Our team understands the drivers which affect pharma and biotech lifecycles and marketing strategies, the research and development which goes into the discovery of novel products and their formulation, their subsequent licensing, distribution and other exploitation, as well as the patent enforcement strategies which complement them. We also understand the competitive/dynamics which drive the generic pharmaceuticals industry.

New joiners

We have recently been joined by two new partners in our Copenhagen office. Anders Valentin and Ole Damsbo are leading Danish patent lawyers. Both Anders and Ole have significant experience and expertise in handling patent litigation, licensing and regulatory matters for pharmaceutical and bioscience clients. Most recently Anders and Ole have been involved in the ongoing battles over generic Omperazol and Atorva-statin. Their contact details are anders.valentine@dlanordic.dk and ole.damsbo@dlanordic.dk.

Patent litigation wall chart

Our Patent Litigation Across Europe wall chart was revised and reissued in 2005. If you have not received a copy and would like to receive one please e-mail amanda.green@dlapiper.com and a copy will be posted to you.

Convergence is a monthly e-newsletter produced by members of our TMC group. Each edition focuses on a different industry within the TMC sector. Editions include: Film & Television, IT and Telecoms, Intellectual Property, Publishing & New Media, Pharmaceuticals & Biosciences, Sport. We also produce a Bi-Annual TMC Review. To subscribe to any of these editions please select from the drop down menu in the right hand panel.

For more information please email: TMCUK@dlapiper.com

If you have been sent this email from a colleague and would like to be added to the mailing list for any of our publications, please send an email to tmcuk@dlapiper.com stating which publications you would like to receive, along with your name, job title, address and email address.